| |
 

Ad Deductibility Remains Under Threat

Members of the House Ways and Means Committee and the Senate Finance Committee are seriously considering taxing advertising in order to raise revenue to finance health care reform.  The current proposal would deny the business expense deduction for the cost of marketing prescription drug products to consumers.  While the immediate target is the pharmaceutical industry, this proposal raises very serious threats for the deductibility of marketing costs for all other products and services.

The two committees are working to develop a package of revenue raisers to offset the costs of health care reform and may vote on the package in the next few days, so time is of the essence.  ADVERTISING DEDUCTIBILITY MUST NOT BE PART OF THAT PACKAGE!   

It is critical that your company immediately contact the members of the House Ways and Means Committee and the Senate Finance Committee to express your opposition to any restriction on the deduction for marketing costs for any product or service. 

Here are some talking points you may want to use in your contacts:

It is critical that you make these contacts immediately.  ANA is working with all other marketing and media associations to let Congress know that we stand united in opposition to any attack on ad deductibility.

A copy of ANA's letter to the tax-writing committees is available here and a letter from The Advertising Coalition is available here.

If you have any questions about this matter, please contact Dan Jaffe (djaffe@ana.net) or Keith Scarborough (kscarborough@ana.net) in ANA's Washington, DC office at (202) 296-1883.  Please let us know of any feedback you get from these contacts.

Legislative and Regulatory Issues Tracking

ANA's Washington, DC office works to protect the ability of all marketers to communicate effectively with consumers.   The scope of legislation, regulations, and court cases impacting the marketing community continues to be extremely broad, extending to issues as diverse as online privacy, prescription drug advertising, restrictions on the tax deductibility of advertising costs and the regulatory powers of the Federal Trade Commission.

Read more >

Compendium of Legislative, Regulatory and Legal Issues

ANA's Washington, DC office plays a leading role in protecting the ability of all marketers to communicate effectively with consumers. At the end of each year, we prepare a Compendium which describes our efforts on the broad range of issues we have faced. 

Read more >

Alliance for Family Entertainment

The ANA Alliance for Family Entertainment (AFE) is a coalition of national advertisers, supported by the ANA, which represents almost 40% of all U.S. television advertising dollars..

Learn more >

SAG/AFTRA

ANA and the American Association of Advertising Agencies (4A’s) conduct broadcast talent negotiations with the Screen Actors Guild (SAG) and the American Federation of Television and Radio Artists (AFTRA) through the Joint Policy Committee, or JPC.

Learn more >